Targeting of the Bmi-1 in stem cells by microRNA-128 inhibits glioma proliferation and self-renewal, implying that miRNA-128 may be a therapeutic target agent for the "stem cell-like" characteristics of glioma[81]. Here, BMI1 is linked to central nervous system cancer.